Quick Takeaways
- STATE STREET CORP filed SCHEDULE 13G for NEUROCRINE BIOSCIENCES INC COMMON STOCK.
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2024.
STATE STREET CORP - 31 Dec 2024 SCHEDULE 13G Report for NEUROCRINE BIOSCIENCES INC COMMON STOCK
- Filing Manager
- STATE STREET CORP
- Reporting Manager
- STATE STREET CORPORATION
- Shares outstanding
- 101,898,688 shares
- Disclosed Ownership
- 4,891,137 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2025, 06:50:04 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"STATE STREET CORP disclosed 4.8% ownership in NEUROCRINE BIOSCIENCES INC COMMON STOCK on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 06:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| STATE STREET CORPORATION | 4.8% | 4,891,137 | 0 | 4,431,623 | ELIZABETH SCHAEFER | SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER |